Amiodarone is an iodinated benzofuran derivative, a highly lipophilic drug with
unpredictable pharmacokinetics. Although originally classified as a class III agent due to its …

Amiodarone was introduced as an antiarrhythmic compound in the early 1970s and was
approved in the US for the treatment of refractory ventricular arrhythmias in late 1984. Since …

Synopsis Amiodarone, originally developed over 20 years ago, is a potent antiarrhythmic
drug with the actions of all antiarrhythmic drug classes. It has been successfully used in the …

Amiodarone is a benzofuran derivative that has been effective for the treatment of both
supraventricular and ventricular tachyarrhythmias. It has a large volume of distribution …

Amiodarone, a complex compound with variegated electropharmacologic and
pharmacokinetic properties and an equally complex side-effect profile, continues to have a …

Amiodarone is an antiarrhythmic agent commonly used in the treatment of supraventricular
and ventricular tachyarrhythmias. This article reviews the results and clinical implications of …

Expanding Indications of Class III Agents. The evidence that antiarrhythmic compounds that
act by slowing conduction velocity increase mortality in patients with cardiac disease is now …

Introduced as an anti-anginal compound in 1962, amiodarone emerged in the 1970s as a
uniquely effective antiarrhythmic and antifibrillatory drug with a multiplicity of properties, the …

Amiodarone has emerged as the leading antiarrhythmic therapy for termination and
prevention of ventricular arrhythmia in different clinical settings because of its proven …

Amiodarone is an antiarrhythmic agent commonly used in the treatment of supraventricular
and ventricular tachyarrhythmias. This paper reviews clinical trials in which amiodarone was …